MultiVir IPO Research Information

MultiVir IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on MultiVir, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
MultiVir	MVIR - NASDAQ	$12.00-$14.00	$0.00	$0.00	4.6 million
Underwriter(s): RBC Capital Markets
Co-Manager(s): Nomura, Cantor Fitzgerald & Co., LifeSci Capital
Industry:
Filing(s): Filed 2015-03-30 Terms Added 2015-04-23

About MultiVir (adapted from MultiVir prospectus):
They are a clinical-stage gene therapy company developing a pipeline of novel product candidates for the treatment of multiple oncological indications.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "MVIR" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.